Our company
+
Activities
+
Sustainability
+
Knowledge center
Products
en
fr
About us
Seqens group
Governance
Scientific committee
Locations
Our Partners
Compliance
R&D
Key expertises
Excellence centers
Innovation Hub
Careers
Join the Seqens adventure
Our Commitment to Youth
Our jobs and our teams
Activities
Pharmaceuticals
Custom & specialties
Personal Care
Cell&Gene
Biotechnologies
News
Our news
Activities
Pharmaceuticals
Custom & Specialties
Personal Care
Cell&gene
Biotechnologies
Sustainability
Vision & Strategy
Environment
Operation integrity
People and Communities
Safety, Quality and Sustainable Innovation
CSR Performance
CSR Library
Show menu
Latest news from SEQENS Group
All news
CSR
Events
General
PERSONAL CARE
Press release
Products & Technologies
Protéus
25/01/2022
General
Update on isopropanol plant expansion
Read more
17/12/2021
General
SK Capital becomes the new majority shareholder of Seqens – Q&A
Read more
16/12/2021
General
Seqens becomes a partner of the RoLA-FLEX project
Read more
24/11/2021
General
Seqens Prize of the French Académie des Sciences 2021
Read more
06/10/2021
Raw materials, energy and transport: rising prices & availability
Read more
07/09/2021
SEQENS unveils its new pharmaceutical quality control laboratory in the presence of Jean Castex, French Prime Minister.
Read more
17/08/2021
General
SEQENS products: essential ingredients for better water
Read more
05/07/2021
General
Labcom HitCat Inauguration in partnership with the CNRS
Read more
14/06/2021
General
Professor Patrick Couvreur joins the Seqens Scientific Council
Read more
01/06/2021
General
3rd Franco-German Technology Dialogue
Read more
20/05/2021
General
Seqens is proud to announce the official partnership between Alganelle and Sederma for the development of a future cosmetic ingredient.
Read more
17/05/2021
General
Biocatalysis: a science in permanent technological evolution
Read more
1
2
3
4
…
6